Metabonomics and its role in drug development and disease diagnosis

Expert Review of Molecular Diagnostics

Volumn 4, Issue 2, 2004, Pages 189-199

  Lindon, John C ^a,b   Holmes, Elaine ^a,b   Nicholson, Jeremy K ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Metabometrix Ltd   (United Kingdom)

Author keywords

Atherosclerosis; Diagnosis; Drug safety; Genomics; Metabonomics; MS; NMR; Proteomics; Transcriptomics

Indexed keywords

NEW DRUG;

ANALYTIC METHOD; BIOINFORMATICS; CHEMOMETRIC ANALYSIS; DATA ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG SCREENING; FOURIER TRANSFORM MASS SPECTROMETRY; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MAGNETIC FIELD; MASS SPECTROMETRY; METABONOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; REPRODUCIBILITY; REVIEW; TOXICITY TESTING;

ANIMALS; COMPUTATIONAL BIOLOGY; DIAGNOSIS; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLISM; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 1542268299     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.4.2.189     Document Type: Review

References (31)

1. Human Genome Program, US Department of Energy. Genomics and Its Impact on Science and Society: A 2003 Primer. US Department of Energy, WA, USA (2003).
2. Scheel J, von Brevern MC, Horlein A, Fischer A, Schneider A, Bach A. Yellow pages to the transcriptome. Pharmacogenomics 3, 791-807 (2002).
3. Kenyon GL, De Marini DM, Fuchs E et al. Defining the mandate of proteomics in the post-genomics era: workshop report. Mol. Cell. Proteomics 1, 763-780 (2002).
4. Raamsdonk LM, Teusink B, Broadhurst D et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnol. 19, 45-50 (2001). Important paper that describes the use of metabolic profiling by gas chromatographic mass spectrometry (MS) to reveal the metabolic consequences of different gene exression profiles.
5. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR data. Xenobiotica 29, 1181-1189 (1999). Short review which introduces the concept and definition of metabonomics.
6. Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn. Reson. 12, 289-320 (2000).
7. Plumb RS, Stumpf CL, Gorenstein MV et al. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun. Mass Spectrom. 16, 1991-1996 (2002).
8. McMaster MC, McMaster C. GC/MS: A Practical User's Guide. John Wiley & Sons, Chichester, UK (1998).
9. Niessen WMA. Liquid Chromatography-Mass Spectrometry. Marcel Dekker, NY, USA (1999).
10. Schmitt J, Beekes M, Brauer A, Udelhoven T, Lasch P, Naumann D. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal. Chem. 74, 3865-3868 (2002).
11. Moka D, Vorreuther R, Schicha H et al. Magic angle spinning proton nuclear magnetic resonance spectroscopic analysis of intact kidney tissue samples. Anal. Commun. 34, 107-109 (1997).
12. Tycko R. Nuclear Magnetic Resonance Probes of Molecular Dynamics. Kluwer Academic Publishers, Dordrecht, The Netherlands (2003).
13. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. Ann. Rep. NMR Spectrom. 38, 1-88 (1999). Comprehensive compilation of the nuclear magnetic resonance (NMR) spectral parameters and assignments for endogenous metabolites in biofluids known at the time.
14. Lindon JC, Nicholson JK, Wilson ID. Directly-coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J. Chromatogr. B 748, 233-258 (2000). Most up-to-date review of the use of the directly-coupled techniques of liquid chromatography, NMR and MS for separation and identification of components of complex mixtures.
15. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Discov. 1, 153-161 (2002). Recent review of the definition of metabonomics and its application to drug safety assessment and evaluation of functional genomics.
16. Coen M, Lenz EM, Nicholson JK, Wilson ID, Pognan F, Lindon JC. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 16, 295-303 (2003).
17. Lamers RJAN, Wessels ECHH, van der Sandt IC et al. A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprinting. J. Nutr. 133, 3080-3084 (2003).
18. El-Deredy W. Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review. NMR Biomed. 10, 99-124 (1997).
19. Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. NMR Spectrosc. 39, 1-40 (2001). Comprehensive and recent review of chemometric techniques and their application in magnetic resonance spectroscopy.
20. Holmes E, Connor SC, Nicholls AW et al. Identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemomet. Intel. Lab. Systems 44, 251-261 (1998).
21. Beckwith-Hall BM, Nicholson JK, Nicholls A et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11, 260-272 (1998).
22. Holmes E, Nicholls A, Lindon JC et al. Chemometric models for toxicity based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471-478 (2000).
23. 1H-NMR spectroscopy of urine and pattern recognition. Anal. Biochem. 295, 194-202 (2001).
24. Lindon JC, Nicholson JK, Holmes E et al. The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137-146 (2003). Overview of the successful COMET project aimed at generating NMR spectral databases of biofluids after administration of a wide range of toxins and derivation of computer-based expert systems for prediction of toxicity.
25. Plumb F, Granger J, Stumpf C, Wilson ID, Evans JA, Lenz EM. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 128, 819-823 (2003).
26. Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences; application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett. 484, 169-174 (2000).
27. 't Hart BA, Vogels JTWE, Spijksma G, Brok HPM, Polman, C, van der Greef J. H-1 NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urine of MS patients and non-human primates with MS-like disease. J. Neurosci. 212, 21-30 (2003).
28. Lamers RJAN, DeGroot J, Spies-Faber EJ et al. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic guinea pigs. J. Nutr. 133, 1776-1780 (2003).
29. 1H-NMR spectra from perchloric acid extracts of human brain biopsies. Magn. Res. Med. 39, 869-877 (1998).
30. 1H-NMR-based metabonomics. Nature Med. 8, 1439-1444 (2002). One of the first applications of metabonomics in a real clinical setting, focusing on diagnosis of atherosclerosis using NMR spectroscopy of blood plasma.
31. Waters NJ, Holmes E, Williams A, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on the time-related metabolic effects of α-naphthylisothiocyanate on liver, urine and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol. 14, 1401-1412 (2001). An integrated NMR-based metabonomics study in the toxicity field using a combination of tissue and biofluid samples.